Separate, medication-specific, new-user cohorts were created
Indeed, generating a fusion or conjugation between a peptide and a carrier molecule such as an antibody Fc fragment 23,24 or a full antibody 25,26 is a well described half-life extension strategy to address their rapid clearance from circulation and improve their therapeutic potential
In this context, GLP-1 therapies may act less by eliminating senescent cells and more by slowing the processes that drive their accumulation over time
We live in a culture which always finds fault with the female body. As well, it makes the pressure to hide body modification even more intense
Improved glycemic control and weight loss may indirectly support brain health, but prescribing tirzepatide specifically for neuroprotection is not FDA-approved
2021 Oct 1;27(5):1321-1343